Operating Partners for AI, Life Sciences & the Founders Rewriting What’s Possible

Breakthroughs don't scale alone.
Yours deserves

We embed senior operators inside companies to build the AI systems, partnerships, and commercial infrastructure that last. Founders stop chasing revenue and return to building what matters.

See The Method Our Story
Scroll
Track Record

Operators who’ve
done the job
you’re asking about.

Every operator we deploy has held P&L, built pipeline from zero, and handed off a system that outlasted them. We know what breaks and when. It’s a pattern we’ve seen enough times to map.

Our Story
0+
VC-backed startups scaled, funded, and exited
What We Do

Work that moves
the business.

Extraordinary science deserves infrastructure built to match. We embed inside the companies creating it, bridging vision and execution across product, revenue, operations, and capital - until the engine runs without us. What remains is a system that makes everyone more effective.

01
Embedded Operating Partners
Senior operators embedded full-time or fractionally inside your company or portfolio. We take ownership of commercial outcomes, not just counsel on them.
EmbeddedExecutionP&L Ownership
02
AI Enablement & Adoption
Enterprise AI that actually gets used. 88% of organizations now use AI in some form. Only 5% generate real returns. The failure isn’t the model - nobody redesigned the workflow around it. We do.
AI StrategyEnablementEnterprise
03
Product Development Strategy
Product strategy at the intersection of AI, biology, life sciences, and healthtech. Most healthcare AI never reaches a patient — not because the science fails, but because the product was never built around how clinicians work, what regulators accept, and how the system buys. We work alongside your product and clinical teams to shape what gets built and why: therapeutics from discovery to the clinic, real-world evidence and data products, and the clinical and access AI deployed at the point of care — designed around real need, real workflow, and real evidence. Product and GTM run as one motion — toward outcomes that reach patients, not pilots that stall.
Discovery to ClinicRWE & DataClinical & Access AI
04
Partnership & Revenue Architecture
The commercial foundation and the partner ecosystem, built as one system. Revenue architecture your team can run, your board can read, and your investors can underwrite — and the channel, co-sell, and enterprise alliances that compound into revenue, not one-off deals.
RevOpsChannelCo-Sell
05
Fractional Chief of Commercial & RevOps
We own the commercial engine end to end — pipeline, new markets, partnerships, and business development — with the RevOps discipline underneath: forecasting, funnel metrics, and board-ready reporting. Before, alongside, or instead of a full-time commercial leader.
CommercialRevOpsGTM
06
Strategic Advisory
The inflection points that determine whether a company reaches the next round, or doesn’t, are rarely solved in the boardroom. We work at the strategic level across fundraising, market expansion, product-market fit, and leadership transitions, bringing domain depth and commercial operator experience that most advisory relationships don’t have access to.
Board ReadyFundraiseScale
The Founder’s Truth

Great companies are rarely out-thought.They’re out-executed.

Our Purpose

Elevating Founders Who Build
What Matters.

Scaling AI & Infrastructure
Founders building and VCs backing the intelligence layer: foundation models and frontier training; compute and inference platforms; agentic systems and orchestration; evaluation and observability; data infrastructure; enterprise AI
Building Real-World Evidence & Data
Founders building and VCs backing the real-world evidence engine: multimodal real-world data across claims, EHR, labs, genomics, SDOH, payer access, and formulary; patient and disease-burden mapping; trial design, eligibility, recruitment, and decentralized delivery; synthetic control arms; regulatory-grade FDA submissions and label expansion; real-time insight; post-market safety; HEOR; commercial launch and market access
Accelerating Therapeutics & Drug Discovery
Founders building and VCs backing the next generation of medicines: target identification; generative design across small molecules, biologics, RNA, and cell and gene therapies; biological foundation models; structure, binding, and developability prediction; autonomous AI scientists and agentic research platforms; integrated discovery platforms and operating systems for the full drug lifecycle — lab-in-the-loop, in silico to clinic
Powering Precision Medicine & Diagnostics
Founders building and VCs backing precision medicine: multimodal foundation models across genomics, multi-omics, imaging, and clinical data; biomarkers; liquid-biopsy and multi-cancer early detection; AI pathology; companion diagnostics; longitudinal disease monitoring
Advancing Health & Longevity
Founders building and VCs backing the science of healthspan: AI aging clocks and biological-age biomarkers; multi-omics models of aging; cellular and partial epigenetic reprogramming; senolytics and regenerative medicine; wearables and continuous health intelligence; cross-species aging research; personalized prevention
Improving Care Delivery & Health Systems
Founders building and VCs backing the future of care: clinical AI, ambient intelligence, and patient data powering decision support and clinical workflow; prior authorization, medication access, and fulfillment; care navigation and adherence; value-based care; payer operations and revenue cycle — all toward better patient outcomes
Kinarête
/ kin·ah·ret /

From kinēsis — movement — and aretē — excellence. The name is the operating standard: excellence, in motion.

It is the measure every engagement is held to — momentum you can underwrite, built to a standard that outlasts us.

Our Ethos

Excellence as a
daily practice.

We built this firm for the companies doing the hardest, most important work and exists for the founders who need an operator, not another advisor.

Our Story
Operators, not consultantsWe hold outcomes, not opinions. Every engagement ends with a system, not a summary.
Kinship with the missionWe choose clients whose work we believe in. Selective by design. Invested for the long run.
Honest over comfortableWe tell founders what the data says, not what they want to hear. That rigour is rarer than it should be, and it’s what builds something that lasts.
Excellence as a disciplineWe hold the same standard on every engagement, at every stage, without exception.
Get Started

Bring us the hardest
problem you have.

You shouldn’t have to choose between the mission and the machine. We exist so you never do.

Book a Discovery Call View Services

Conversations are confidential. No deck required.

Services

How we
operate
inside
your company.

Start with a Diagnostic See The Method
01
Embedded
We work inside your company,
not outside it.
We operate inside the business, inside the culture, until the engine runs without us.
02
Accountable
We own the outcome,
not just the advice.
We build the systems, develop the team, and stay until the revenue motion runs on its own.
03
Transferable
The goal is to make
ourselves unnecessary.
Every engagement ends with a commercial infrastructure your team owns, understands, and can run independently.
The Difference

What operators do
that advisors don’t.

Most firms tell you what to do. We come in and do it, inside your company, with your team, owning the outcome. Accountability means something different when you’re in the room.

Advisory model
Recommendations delivered. Execution left to you.
Kinarête model
Embedded operators who hold the outcome.
Weekly calls. Slide decks. Workshops.
In the data room. In the pipeline. In the boardroom. In the hard conversations.
You implement. You figure out why it doesn’t work.
We debug alongside you, and drive adoption, in real time.
Engagement ends. You start from scratch.
We leave you a machine that runs without us.
“
We’ve put Kinarête’s founder into three portfolio companies. Every one of them had a repeatable revenue engine within two quarters. She earned trust within each company and with their biggest clients. Most people build the commercial model or the systems. She does both, and they actually talk to each other.
Early Stage Venture Capital, New York
Kinarête built our partner ecosystem from the ground up. Strategy, relationships, co-selling motions, all of it. Partnerships we expected to take years closed in months, and on stronger terms than we’d originally scoped.
Series B Healthtech AI Founder & CEO
Kinarête came referred after we’d been underwhelmed by a top management consultancy and a leader in our industry, neither could tell my team anything we didn’t already know. I was the last person in the room to buy in. Kinarête’s founder is different, she is a builder who understands the science and global market dynamics at depth. Our new agentic product is better and our go-to-market is stronger because she refused to separate the two, and she did it with an integrity that raised the bar for the whole operation. She got our product and GTM teams operating as one.
Head of Product, Enterprise AI
I’d worked with top mentors and advisors in our industry. None of them opened the doors Kinarête’s founder did. She made warm introductions to investors, VCs, and talent that completely changed our trajectory. Not because we were a line item, but because she genuinely believed in what we were building. She actually turned down payment during our seed stage and told us to invest it back into the company. That’s rare, and we never forgot it.
Series B CEO, Human Health
Kinarête’s founder is relentless and operationally airtight. Nothing falls through, nothing stalls. She gets it.
Founder, AI Research & Product
Where to Start

Most engagements start with a
Diagnostic.

A focused 4–8 week assessment that maps your product, commercial, and operational landscape and delivers a prioritized roadmap. Clarity in weeks, not quarters.

The Diagnostic includes
ICP validation, product-revenue alignment, and competitive positioning
Voice of the customer and market: what buyers need and where the market is moving
Revenue architecture: CARR waterfall, unit economics, and pipeline integrity
Sales process and team capacity vs. quota reality
Partnership landscape, BD opportunity mapping, and activated vs. signed assessment
AI and automation readiness across the commercial and operating stack
When applicable, regulatory, market access, and governance readiness across markets
Financial clarity and capital narrative: burn relative to growth, board-ready metrics, and fundraise forecast
Clear engagement recommendation, or honest direction if we’re not the right fit
Start with a Diagnostic
The Method

The Revenue
Architecture
Method™

Extraordinary science, remarkable missions, and great products don’t scale alone. Systems carry them. Fewer than one in five seed-funded companies now reaches Series A - half the rate of just five years ago - and Seed through Series C, the stall has a remarkably consistent diagnosis: growth outran the founder and founding team’s motion, and nothing repeatable was built to take the weight. Investors call it the graduation problem. We call it a missing system. The Revenue Architecture Method™ is a 5-phase operating system built for exactly that moment.

Phase 1
Diagnostic
Phase 2
Blueprint
Phase 3
Execution
Phase 4
Scale
Phase 5
Transfer
The system holds. The founder returns to the mission.
01
Diagnostic
02
Blueprint
03
Execution
04
Scale
05
Transition
1
Phase 01

Revenue Diagnostic

Map every surface. Find what to fix first.

Revenue problems are rarely where founders think they are. In the first 4–8 weeks, we map the entire operating surface across commercial, talent, financial, and product dimensions. The fractures are almost always the same: the motion is personality-dependent, the ICP is a logo list, the data doesn’t support the story being told to the board, and the team structure hasn’t caught up with the stage. We find the order in which to act. Then we act.

We examine
Product-market fit stage: which archetype applies and what it means for commercial sequencing
Product positioning: is the market narrative aligned to how buyers actually decide?
Product-revenue alignment: whether what’s being built maps to the job to be done — the workflow it must live in, the evidence buyers require, and which use cases are worth pursuing first
Voice of the customer and market: deep listening with your customers, prospects, and the broader market — understanding what buyers need, where the market is moving, and anticipating what it will ask for next, so the wins work for everyone at the table
Pipeline architecture: where deals originate, stall, and die
Sales motion integrity: repeatable system or founder dependency?
Partnership landscape: who you should be selling with, not just to
BD adjacencies: new markets, categories, and distribution channels not yet in play
Talent and org structure: does the team match the stage, and are the right seats filled?
AI and data infrastructure: does the measurement layer actually exist?
Financial clarity: unit economics, burn relative to growth, and where the model has leverage
When applicable, Global regulatory and market access landscape: how external constraints shape what you can sell, to whom, where, and when
Deliverable
A Revenue Architecture Diagnostic: the unvarnished operating picture, prioritized by impact. What to fix, what to sequence, and what to ignore. The roadmap we execute against together.
2
Phase 02

Commercial Blueprint

Build the system before you hire into it.

Build the system first, and every hire that follows multiplies it. We design the full commercial and operational architecture from first principles: the revenue system, the org that runs it, the processes and AI-enabled workflows behind it, and the infrastructure that connects them. What works with one rep works with ten. What works at Series B holds at Series C.

We design
ICP with real specificity: the intersection of problem fit, authority, and expansion potential
Product positioning and market narrative: how buyers understand the value and why they choose it
Product development strategy: use-case prioritization and roadmap sequencing — what to build first, what to defer, and why — architected for deep workflow integration and the proprietary data moats that make products durable
Revenue motion architecture: direct, channel, PLG, enterprise, or hybrid
Pricing structure aligned to actual buyer value, not competitor anchoring
Talent architecture: the org design, role definitions, and hiring sequence the business actually needs
Operational processes and workflows: how the team executes without the founder in every room
AI workflow architecture: where AI carries the load across the commercial and operating motion, designed in from the start rather than bolted on
CRM and RevOps infrastructure: built to measure what actually matters
Partnership and BD framework: alliance strategy that creates defensible distribution
When applicable, Governance and compliance framework: the operational infrastructure that meets healthcare privacy, security, and regulatory requirements across jurisdictions — HIPAA at home, the emerging AI and data regimes abroad
Deliverable
A Commercial and Operational Blueprint: the complete system design across revenue motion, operational infrastructure, AI-enabled workflows, and team architecture — with a product strategy shaped by the voice of the customer and market. Every decision documented, every dependency mapped, ready to execute from day one.
3
Phase 03

Embedded Execution

We go in and do the work.

The work happens in the field. We carry the quota, work deals alongside your team, pressure-test the GTM motion and product positioning in live selling situations, surface what the market is actually telling you about the product, support the executive search, and build each process by running it. Every system we design, we also implement.

“The transition from founder-led to system-led is the hardest thing a company does. This is where it happens.”
We execute
Quota-carrying pipeline development: we work and close deals
GTM motion execution: segmenting and running enterprise, mid-market, and PLG so they aren’t pulling against each other
Enterprise and strategic partnership origination and close
Design-partner and pilot programs run to convert: pilot structures and data-use terms built for production
A direct line from field to build: an operating rhythm connecting Commercial, Clinical when relevant, Engineering, and Product - so the customer’s voice reaches the roadmap intact
Executive search support: profile, pipeline, and assessment for revenue-critical hires
Team coaching in the field, on live deals, not in a training room
Revenue intelligence and financial modeling: a single source of truth across pipeline and performance data, connected directly to forecasting so the number is defensible
Weekly pipeline reviews with board-ready reporting and narrative
AI tooling integration across Operations, Commercial, BD, and RevOps workflows
Deliverable
A functioning revenue engine. Pipeline moving, GTM motion tested and segmented, partnerships in flight, financial model connected to live data, team executing without the founder in every room.
4
Phase 04

Scale & Optimize

Make it compound. Make it institutional.

Pipeline velocity optimization and bottleneck removal by segment
Channel expansion and partner ecosystem growth
New market and BD pipeline running in parallel to core revenue
Product roadmap aligned to commercial priorities: the expansion use cases, packaging, and pilots that convert into production deployments and multi-year commitments
AI and automation leverage compounding across the motion: more of the system running without adding headcount
Financial modeling and unit economics: CAC, LTV, payback period, and the levers that move them
Board-level reporting: governance-grade metrics that hold up in front of any investor
Fundraising narrative and data room preparation: the story the metrics actually support
When applicable, Market access and revenue pathway: how coverage, access, and approval structures affect revenue at scale
When applicable, Regulatory milestone integration: aligning approval and compliance timelines with commercial launch sequencing
Deliverable
A scaling revenue engine with playbooks, metrics, and a fundraising narrative that holds up in the boardroom and the next raise.
5
Phase 05

Transition & Transfer

Hand off the engine. Get your time back.

Complete playbook documentation: every motion, decision, and framework recorded
Product-commercial alignment framework handed off, so the roadmap stays connected to what the market is actually telling you
AI and automation stack documented, adopted, and running without us
Permanent leadership placement: profile definition, search support, and structured onboarding
Full team knowledge transfer and capability assessment: nothing leaves with us
30/60/90-day transition plan for the incoming leader, so the system doesn’t reset
Deliverable
An institution built to outlast the engagement. The incoming leader inherits a system with every decision, motion, and framework already inside it. The team executes. The founder leads. The mission advances.

“Good operators make themselves redundant. The infrastructure outlasts the engagement. The work is done when the founder stops chasing revenue and gets back to leading the mission.”

Get Started

Most engagements start
with a Diagnostic.

In 4–8 weeks, we conduct a full operating diagnostic and deliver a prioritized roadmap. Revenue architecture, product-revenue alignment, operational infrastructure, and financial clarity. Prioritized. Ready to act on.

Start with a Diagnostic
Ethos

The operator
behind the
architecture.

I’ve spent 15 years inside companies at the intersection of AI, life sciences, healthtech and emerging technology. Not advising from the outside, but building alongside founders, turning their vision into systems that outlast me.

The Story

Why I
built this.

I founded Kinarête Partners because the companies doing the most important work in AI, life sciences and healthtech often have extraordinary science and not enough commercial and operational infrastructure to match it.

They don’t need another advisor. They need someone who’s built the machine before, learned from where it broke, and will build it again, better, inside their business, with their team, until it runs without them.

“When the commercial engine works, founders get something back that no amount of funding can buy: their time, their focus, and the freedom to lead the mission they started.”

The name means something. Kinarête comes from the Greek idea of excellence through virtuous action — not excellence as an outcome, but as a daily practice. And in its first syllable, kin: kinship, kindred, the people you build with and build for.

That’s the work. Building things that last, in service of the people and missions that matter.

Book a Conversation Our Services
What We See

Funding solves for belief.
Operations solve for everything else.

The Capital Shift
More capital is chasing fewer categories than at any point in the last decade. The constraint was never funding. It’s always been execution.
AI captured 61% of all global venture capital in 2025. BCG found that 74% of those companies still struggle to convert that investment into measurable scale. The bottleneck is not belief in the category. Every GP in the room believes. It is the commercial infrastructure required to realize it. Capital allocates to vision. Operations determine whether the vision compounds.
The Operator Gap
The venture model funds the vision and opens the network. Execution at the operating level requires a different kind of presence.
The best VC platforms provide capital, pattern recognition, and access that no founder can replicate alone. What they are not designed to provide is an operator who embeds inside the company, takes ownership of the full operating picture across commercial infrastructure, revenue systems, product positioning, team architecture, and the financial model that connects them, and builds it from the inside. 44% of founders say GTM is where they need the most support. Only 23% feel they received it. That is not a criticism of the model. It is the structural reality of how the model was designed. Kinarête exists in that gap.
The AI Adoption Wall
The technology works. The organization doesn’t change. That is almost always the diagnosis.
In 2025, 42% of companies abandoned most of their AI projects entirely, up from 17% the year before. AI does not fail at the model layer. It fails at the operating layer, the point where a new capability has to displace an existing behavior, which means displacing the incentives, workflows, and habits built around the old one. The companies that crossed that gap didn’t do it with better tools or bigger budgets. They did it with someone inside who owned the transition and was accountable for the outcome.
The Founder Trap
Founder-led sales is the right motion at zero to one. It is the wrong infrastructure at one to ten. Most companies don’t notice the difference until it’s already structural.
Building a repeatable commercial motion takes a minimum of two years. The founders who wait until the board asks for it are already eighteen months behind. The ones who move early don’t just hit the number. They build the system that makes the number predictable, transferable, and fundable at the next round. Revenue that lives in one person is not a commercial engine. It is a single point of failure with a good quarter.
The Partnership Gap
Most portfolio companies never build the partnership motion deliberately. It gets delegated, then deprioritized, then quietly dropped. The compounding never starts.
Companies with mature partnership programs grow revenue nearly twice as fast and generate 28% of revenue through the channel. ICONIQ found that a deliberate channel motion shortens average sales cycles by 25%. The founders who build this early don’t just grow faster. They create distribution architecture that makes the next competitive threat harder to replicate and the next round easier to underwrite. The ones who don’t are still selling the same way they were at Series A.
Contact

Tell us
what you’re
building.

We’ll be in touch within 48 hours. If you’re not sure where to start, the form is a good place. Or skip ahead and book a call directly.

This engagement is right for you if
You’re a founder who has outgrown founder-led sales and needs an operator inside the company
You’re a VC who wants an operator inside a portfolio company to align product and GTM, drive hypergrowth, and build the systems that hold at scale
You’re building RWE, data, or AI products for life sciences and healthcare, and the evidence and the commercial model need to hold up together
You’re building, selling, or investing in enterprise AI — and adoption is stuck between pilot and production
You’re at a commercial inflection point and can’t afford to wait for the right permanent hire — or want the system built and the role defined before you make one
You’re a founder whose best hours go to putting out fires and chasing revenue, over your mission
How we approach it
Bring us the hard problem. You’ll leave with a clear read and a concrete next move.
Your information
* required
Drop files here or click to browse
Any format
Discovery Call

Twenty-five
minutes.
No prep needed.

Every partnership starts with a conversation. Come ready to talk about your mission: where you are, where you’re stuck, and what you’re trying to build.

Minutes 1–10
You tell us what you’re building and where the engine is breaking down.
Minutes 10–20
Open Q&A. We pressure-test what we’re hearing and share the patterns we’ve seen inside companies at your stage — what’s likely happening, and why.
Minutes 20–25
We discuss what a potential engagement looks like, or point you in the right direction if we’re not the right fit.
For angel investment inquiries
Please reach us directly at invest@kinarete.ai
Select a time
Discovery Call
25 minutes Complimentary
Loading availability
Book directly
The embedded calendar can’t load in this view.

Open the scheduler in a new tab to see live availability and confirm your discovery call. It takes under a minute.

Open the Scheduler
You’ll receive a calendar invitation with the Zoom link.
Open in a new tab
Vol. I  ·  2026
Field Notes

Notes from
inside the build.

What operators actually see when they’re inside companies doing the hardest work. Not theory. Not frameworks. Patterns from the field.

Coming Soon

The first dispatches
are on their way.

We launch in the coming weeks. Leave your details and you’ll be the first to receive them - patterns from the field, written for founders still inside the build.

No noise. No cadence. First dispatch only - when it’s ready.

Work With Us

The writing is the thinking.
The work is the build.

If a pattern here looks like your company, let’s talk.

Book a Discovery Call Send a Note